Latest News
A new study from the Yale School of Public Health (YSPH) offers fresh insights into our understanding of colorectal cancer (CRC) that challenge the conventional right-sided and left-sided classifications of the disease.
- April 01, 2024
Yale Cancer Center researchers will present their new cancer research findings at the 2024 AACR annual meeting. A few of the presenting YCC researchers offer their key study takeaways and the significance for patients and oncologists.
- December 11, 2023
In a new study by researchers at the Yale School of Public Health, two “forever chemicals” spurred cancer cells in the lab to migrate to new positions, an indication that the chemicals could contribute to cancer metastasis in living organisms.
- September 19, 2023
Colon cancers that spread to the liver may be substantially different depending on the location where cancerous cells originate, according to new research.
- September 13, 2023
Yale researchers identify diet-related metabolites associated with paraben concentrations in the urine of pregnant women. Parabens can disrupt endocrine activity in the body and they have been associated with changes in fertility in women.
- April 26, 2023Source: Yale News
Around 40% of colorectal cancer patients have a particular gene mutation. A new study shows it’s linked to reduced cell death and worse survival rates in men.
- April 04, 2022
African-American adult patients are more likely than white patients to receive substandard gastrointestinal cancer surgery, according a large study led by researchers at Yale Cancer Center. The findings are reported today in the journal JAMA Network Open.
- July 21, 2021
Colon cancer has been undergoing a similar subdivision. Researchers have known for years that colorectal cancer is the third most common cancer diagnosis in the United States and the second leading cause of cancer-related deaths. The National Cancer Institute estimates 149,500 new cases in 2021 and 53,000 deaths.
- July 06, 2021Source: Yale News
Researchers studying COVID-19 patients have found a metabolic pathway that is highly correlated with immune responses only in male patients, a group known to be more likely to suffer severe cases and die of the disease, representing a potential target for therapeutic intervention.
- July 05, 2021Source: New York Times
Colon and rectal cancers are rising in younger adults, though researchers aren’t sure why. A new study of women and diet suggests that sugar-sweetened drinks may play a role.